science

Studying of the role of genetic (biotransformation enzymes) and environmental factors, homeostasis correctors is the recent research direction of Clinical Pharmacy and Clinical Pharmacology Department.

The efficacy of metabolic correctors in internal diseases is a prioroty of the scientific work of the Department. First in Ukraine the connection of a detoxic enzyme N-acetyltransferase with a health status of the young in populational processes was found; moreover, its role in an individual response on a standard pharmacotherapy of bronchial asthma, diabetes melitus, ischemic heart disease, drugs toxicity risk was set. An effectiveness of domestic pharmaceuticals («Corargin», «Thiotriazoline», «HAES-LX» etc.) is studied in the Department. Most of the researches in the Department concern the protective effects of drugs on cardiovascular and pulmonary systems, kidneys, liver, brain.

19 PhD and 9 Magister degrees were got under Professor Yakovleva's direction; 9 young scientists are working on their doctoral and pre-doctoral dissertations.

The following research work is ongoing in the Clinical Pharmacy and Clinical Pharmacology Department:

«Organoprotective effectiveness and safety of metabolic correctors in the treatment of comorbid pathologies».